期刊名称：MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Menopause provides a forum for new research, applied basic science, and clinical guidelines on all aspects of menopause. The scope and usefulness of the journal extend beyond gynecology, encompassing many varied biomedical areas, including internal medicine, family practice, medical subspecialties such as cardiology and geriatrics, epidemiology, pathology, sociology, psychology, anthropology, and pharmacology. This forum is essential to help integrate these areas, highlight needs for future research, and enhance health care.
Instructions to Authors
Scope
Menopause is the official journal of The North American Menopause Society (NAMS). A peer-reviewed scientific journal, Menopause provides a forum for new research, applied basic science, and clinical guidelines on all aspects of menopause. The scope of the journal extends beyond gynecology, encompassing multidisciplinary areas that include internal medicine, family practice, medical subspecialties such as cardiology and geriatrics, epidemiology, pathology, physiology, sociology, psychology, anthropology, and pharmacology.
Manuscript Submission
A submitted manuscript must be an original contribution not previously published (except as an abstract or preliminary report), must not be under consideration for publication elsewhere, and, if accepted, must not be published elsewhere in similar form, in any language, without the consent of Lippincott Williams & Wilkins. Each person listed as an author is expected to have participated in the study to a significant extent. Although the editors and referees make every effort to ensure the validity of published manuscripts, the final responsibility rests with the authors, not with the Journal, its editors, or the publisher.
All manuscripts must be submitted on-line through the Menopause Editorial Web Site (http://meno.edmgr.com). First-time Users: Click the Register Button from the main menu and enter the requested information. Upon successful registration, you will receive an e-mail with your user name and password. Print a copy of this information for future reference. Once you have received a user name and password, never register again, even if your status changes (as author, reviewer, or editor). Authors: Click the Login Button from the menu at the top of the page and enter the system as an Author. Submit your manuscript according to the author instructions. This Web site also provides an opportunity to track the progress of your manuscript through the peer review process. If you have any questions, please contact:
Diane K. Barker
Managing Editor
E-mail: dbarker1@partners.org
Telephone: (617)724-1372
Fax: (617)724-0988.
Preparation of Manuscripts
All manuscripts submitted to Menopause should adhere to the ‘‘Uniform Requirements for Manuscripts Submitted to Biomedical Journals.’’ Manuscripts must be written in English. Authors whose native language is not English should have their manuscripts checked for correct English grammar prior to submission. Upon submission, if the grammar is considered to be unsuitable by the Editor-in-Chief, the paper will be returned to the corresponding author for necessary revisions prior to being sent out for peer review. All text is subject to editorial revision and review. The author should retain a copy of the complete submission for reference.
Brief Reports: Reports should present focused, new clinical or investigational observations in a format of three to four typeset pages (including references) and a maximum of two illustrations or tables.
Original Articles: Articles covering both basic science and clinical topics are welcome. In most cases, each article receives at least two editorial peer reviews and one statistical review.
Letters to Editor: Letters to the Editor are encouraged and should be submitted in response to work that has already been published in Menopause. They may be submitted to the journal’s Managing Editor and addressed to the Editor-in-Chief. Letters should be in typewritten form. They may also be submitted online as a manuscript (see instructions for Manuscript Submission). Letters should not exceed 400 words (excluding references, names/addresses). References should not exceed five, with the related article being one of the five citations. Complete references must be supplied in the proper format (see below). Also provide an address for correspondence. If the letter is accepted for publication the authors of the article that prompted the letter will be given an opportunity to reply.
Details of Style. Please follow the guidelines set by the American Medical Association Manual of Style, 9th edition, Williams & Wilkins, 1998. The manuscript must include (in the following order): the title page, abstract, text, acknowledgments, references, tables, figure legends, and figures. Each of these sections should start on a new page, numbered consecutively in the upper right corner.
The electronic version will be typeset and should not contain any extraneous formatting instructions. For example:
- Use hard carriage returns only at the end of paragraphs and display lines (eg, titles, subheadings)
- Do not use an extra hard return between paragraphs
- Do not use tabs or extra space at the start of a paragraph or for list entries
- Do not indent run over lines in references
- Turn off line spacing
- Turn off hyphenation and justification
- Do not specify page breaks, page numbers, or headers
- Do not specify typeface
- Care should be taken to correctly enter ‘‘one’’ (1) and lower case ‘‘el’’ (l), as well as ‘‘zero’’ (0) and capital ‘‘oh’’ (O).
Please observe the following conventions concerning dashes:
- Use a single hyphen with space before it for a minus sign, use a double hyphen (with space before and after) to indicate a ‘‘long dash’’ in text, use a single hyphen (with no extra space) to indicate a range of numbers (eg, ‘‘23-45’’).
- Illustrations and tables will be handled conventionally. However, figure and table legends should be included at the end of the electronic file.
- Nonstandard characters (Greek letters, mathematical symbols, etc.) should be coded consistently throughout the text. Please make a list of such characters and provide a listing of the codes used.
Title Page: The title page should contain, in order, the following: the paper’s full title; a running title of no longer than 45 characters and spaces combined; author line with the first name, middle initial, last name, credentials (eg, MD, PhD), and affiliation of each author; any source(s) of financial support; disclaimers, if any; name, address, phone and fax number, and e-mail address of the author to whom reprint requests should be addressed (if reprints will not be available, please state so). Indicate which author should receive correspondence and provide that person’s preferred mailing address, telephone and fax numbers, and e-mail address if different from that indicated by the authors for reprint requests.
The title page must also include disclosure of funding received for this work from any of the following organizations: National Institutes of Health (NIH); Wellcome Trust; Howard Hughes Medical Institute (HHMI); and other(s).
Structured Abstract: On the next page, provide an abstract of 250 words or less, organized under the following headings: Objective, Methods, Results, and Conclusions. Also provide with the abstract no more than six key words for database searching.
Text: Begin the body of the manuscript on the next page following the abstract. Although not appropriate for some articles, most regular manuscripts should adhere to the following sequence: Introduction, Methods, Results, Discussion, Conclusions, References, Tables, Legends, and Figures.
Drug Names: Use only generic names when referring to drugs. If a trade name is necessary for clarity, place it in parentheses after the generic name. Do not use registration marks or trademarks.
Terminology: When describing postmenopausal hormone therapy, use the words ‘‘estrogen plus progestogen therapy,’’ abbreviated EPT, to describe this combination hormone therapy or ‘‘estrogen therapy,’’ abbreviated ET, to describe treatment with this hormone alone. ‘‘Hormone therapy,’’ abbreviated HT, should be used as an umbrella term to describe both ET and EPT. Use the word ‘‘progestogen’’ as the umbrella term for progestin and progesterone. Use ‘‘progestin’’ and ‘‘progesterone’’ only for those specific agents.
Abbreviations: Keep abbreviations to a minimum and define each at its first use. Do not use abbreviations in the abstract. Abbreviate units of measure only when used with numbers, and refer to the AMA Manual of Style for standard scientific abbreviations.
Conflicts of Interest and Source of Funding: (if relevant) should be noted in a footnote on the title page.
References: The number of references should not exceed 75 whenever possible. Accuracy of reference data is the responsibility of the author. Number references in the order of their use in the text; do not alphabetize. Identify references in the text with Arabic superscript numerals. Follow the Index Medicus reference style (see ‘‘Uniform Requirements for Manuscripts Submitted to Biomedical Journals,’’ Ann Intern Med 1988; 108:258-265). Provide article titles and inclusive pages. Refer to the List of Journals Indexed in Index Medicus for abbreviations of journal names. List all authors when six or fewer; when seven or more, list only the first three and ‘‘et al.’’ The following are examples of correct format. Refer to the AMA Manual of Style for other examples.
Journal Article
1. Halbreich U, Rojansky N, Palter S. Decreased bone mineral density in medicated psychiatric patients. Psychosom Med 1995;57:485-491.
Chapter in a Book
2. Byrne JLB. The role of oral contraceptives. In: Wilansky S., Willerson JT, editors. Heart Disease in Women. New York, NY: Churchill Livingstone, 2002:122-127.
Book
3. Rock JA, Jones HW III, ed. TeLinde’s Operative Gynecology, Ninth Edition. Philadelphia, PA: Lippincott Williams & Wilkins, 2003.
Web Site
4. Gapstur SM, Morrow M, Sellers TA. Hormone replacement therapy and risk of breast cancer with a favorable histology. JAMA[serial online].1999;281:2091-2097. Available at: http:// jama.ama-assn.org/issues/v281n22/full/joc90096.html. Accessed November 15, 1999.
5. The North American Menopause Society. Definitions and statistics. Available at: http://www.menopause.org/aboutmeno/ overview.htm. Accessed February 15, 2005.
Digital Figures: Electronic art should be created/scanned and saved and submitted as either a TIFF (tagged image file format), an EPS (encapsulated PostScript) file, or a PPT (PowerPoint) file. Line art must have a resolution of at least 1,200 dpi (dots per inch), and electronic photographs (eg, radiographs, CT scans) and scanned images must have a resolution of at least 300 dpi. If fonts are used in the artwork, they must be converted to paths or outlines or they must be embedded in the files. Color images must be created/scanned and saved, then submitted as CMYK files. All electronic art must be accompanied by high-resolution laser prints of the images. Please note that artwork generated from office suite programs such as CorelDRAW and MS Word and artwork downloaded from the Internet (JPEG or GIF files) cannot be used. Cite figures consecutively on the site, and number them in the order in which they are discussed. All electronic art that cannot be successfully uploaded must be submitted on a 3.5 inch high-density disk, a CD-ROM, or an Iomega Zip disk.
Supplemental Digital Content
Supplemental Digital Content (SDC): Authors may submit SDC via Editorial Manager to LWW journals that enhance their article’s text to be considered for online posting. SDC may include standard media such as text documents, graphs, audio, video, etc. On the Attach Files page of the submission process, please select Supplemental Audio, Video, or Data for your uploaded file as the Submission Item. If an article with SDC is accepted, our production staff will create a URL with the SDC file. The URL will be placed in the call-out within the article. SDC files are not copy-edited by LWW staff, they will be presented digitally as submitted. For a list of all available file types and detailed instructions, please visit http://links.lww.com/A142.
SDC Call-outs
Supplemental Digital Content must be cited consecutively in the text of the submitted manuscript. Citations should include the type of material submitted (Audio, Figure, Table, etc.), be clearly labeled as “Supplemental Digital Content,” include the sequential list number, and provide a description of the supplemental content. All descriptive text should be included in the call-out as it will not appear elsewhere in the article.
Example:
We performed many tests on the degrees of flexibility in the elbow (see Video, Supplemental Digital Content 1, which demonstrates elbow flexibility) and found our results inconclusive.
List of Supplemental Digital Content
A listing of Supplemental Digital Content must be submitted at the end of the manuscript file. Include the SDC number and file type of the Supplemental Digital Content. This text will be removed by our production staff and not be published.
Example:
Supplemental Digital Content 1. wmv
SDC File Requirements
All acceptable file types are permissible up to 10 MBs. For audio or video files greater than 10 MBs, authors should first query the journal office for approval. For a list of all available file types and detailed instructions, please visit http://links.lww.com/A142.
Page Charges. There is currently no submission fee for the journal Menopause.
Permissions. To reprint material that has appeared in or has been adapted from previously published works, the author(s) must obtain written permission from the copyright holder and/or author. Include full credit to the original source in the title or legend of the borrowed material. Photos depicting a recognizable individual must be accompanied by a signed release from that person, explicitly granting permission to publish the illustration. Permission documentation must be submitted with the manuscript or soon thereafter.
After Acceptance
Page Proofs and Corrections: Corresponding authors will receive electronic page proofs to check the copyedited and typeset article before publication. Portable document format (PDF) files of the typeset pages and support documents (eg, reprint order form) will be sent to the corresponding author by e-mail. Complete instructions will be provided with the e-mail for downloading and printing the files and for faxing the corrected page proofs to the publisher. It is the author’s responsibility to ensure that there are no errors in the proofs. Changes that have been made to conform to journal style will stand if they do not alter the author’s meaning. Only the most critical changes to the accuracy of the content will be made. Changes that are stylistic or are a reworking of previously accepted material will be disallowed. The publisher reserves the right to deny any changes that do not affect the accuracy of the content. Authors may be charged for alterations to the proofs beyond those required to correct errors or to answer queries. Proofs must be checked carefully and corrections faxed within 24 to 48 hours of receipt, as requested in the cover letter accompanying the page proofs.
Copyright: Copyright on all accepted manuscripts will be held by The North American Menopause Society (NAMS). Current U.S. copyright law makes it necessary to obtain a signed statement from the primary author(s), expressly transferring copyright in the event that the manuscript is published in Menopause. Manuscripts will be considered received by the Editor-in-Chief only when accompanied by a copyright transfer form signed by the first and last authors. Manuscripts published in Menopause become the property of the journal and may not be published elsewhere without written permission from both NAMS and Lippincott Williams & Wilkins.
Compliance with NIH and Other Research Funding Agency Accessibility Requirements: A number of research funding agencies now require or request authors to submit the post-print (the article after peer review and acceptance but not the final published article) to a repository that is accessible online by all without charge. As a service to our authors, LWW will identify to the National Library of Medicine (NLM) articles that require deposit and will transmit the post-print of an article based on research funded in whole or in part by the National Institutes of Health, Wellcome Trust, Howard Hughes Medical Institute, or other funding agencies to PubMed Central. The revised Copyright Transfer Agreement provides the mechanism.
Reprints: Authors will receive a reprint order form and a price list with the page proofs. Reprint requests should be faxed with the corrected proofs, if possible. Reprints are normally shipped 6 to 8 weeks after publication of the issue in which the item appears. For questions regarding reprints, contact: Reprint Department, Lippincott Williams & Wilkins, 351W. Camden Street, Baltimore, MD 21201; Fax: (410) 528-4434; E-mail: reprints@wolterskluwer.com.
Publisher's Contact: Fax corrected page proofs, reprint order form, and any other related materials to Production Editor, Menopause, at (410) 361-8040, (410) 528-4266, or (443) 451-8189.
Editorial Board
Editorial Board
|
Editor-in-Chief
Isaac Schiff, MD
Chief, Department of Obstetrics and Gynecology
The Woman's Care Division
Massachusetts General Hospital
Joe Vincent Meigs Professor of Gynecology
Harvard Medical School
55 Fruit Street FH508
Boston, MA 02114
Phone: 617-726-3001
Fax: 617-726-7548 |
Editor |
|
Margery L.S. Gass, MD, NCMP
Executive Director
The North American Menopause Society
Consultant, Cleveland Clinic for Specialized Women’s Health
5900 Landerbrook Drive, Suite 390
Mayfield Heights, OH 44124
Telephone: (440) 442-7550
Telefax: (440) 442-2660
E-mail: mgass@menopause.org
|
Founding Editor |
Wulf H. Utian, MD, PhD, DSc(Med)
Honorary Founding President and Executive Director Emeritus
The North American Menopause Society
Telephone: (216) 272-7751
E-mail: wulf@utianllc.com |
Managing Editor |
Diane K. Barker
Massachusetts General Hospital
55 Fruit Street FH524B
Boston, MA 02114
Phone: 617-724-1372
Fax: 617-724-0988
dbarker1@partners.org |
Journal Website Editor |
Sharon A. Somerville
The North American Menopause Society
5900 Landerbrook Drive, Suite 390
Mayfield Heights, OH 44124
Telephone: (440) 442-7729
Telefax: (440) 442-2660
E-mail: Sharon@menopause.org |
Editorial Board
| |
Stanley E. Althof, PhD
Case Western Reserve University
Cleveland, OH
David F. Archer, MD
Eastern Virginia Medical School
Norfolk, VA
Nancy E. Avis, PhD
Wake Forest University School of Medicine
Winston-Salem, NC
Gloria A. Bachmann, MD
Robert Wood Johnson Medical School
New Brunswick, NJ
David H. Barlow, MD
FRCOG, FRSE
The University of Glasgow
Glasgow, Scotland
Elizabeth Barrett-Connor, MD
University of California, San Diego
La Jolla, CA
Rosemary Basson, FRCP (UK)
University of British Columbia
Vancouver, BC, Canada
Sarah L. Berga, MD
Emory University School of Medicine
Atlanta, GA
Stanley Birge, MD
Washington University
St. Louis, MO
Celine Bouchard, MD
Laval University
Quebec City, QC, Canada
Amnon Brzezinski, MD
Hadassah-Hebrew University Medical School
Jerusalem, Israel
Henry G. Burger, MD
Monash University
Clayton, VIC, Australia
Robert F. Casper, MD
University of Toronto
Toronto, ON, Canada
Cuauhtemoc Celis-Gonzalez, MD
Universidad Anahuac
Mexico City, Mexico
Thomas B. Clarkson, DVM
Wake Forest University School of Medicine
Winston-Salem, NC
Elizabeth Contestabile, RN, BScN
Ottawa Hospital
Ottawa, ON, Canada
Sybil L. Crawford, PhD
University of Massachusetts Medical School
Worcester, MA
Susan R. Davis, MBBS, FRACP,PhD
Monash University
Prahran, VIC, Australia
Lorraine Dennerstein, PhD
University of Melbourne
Parkville, VIC, Australia
Bruce Ettinger, MD
San Francisco, CA
Marcha P. Flint, PhD, PsyD
Montclair State University
Verona, NJ
Robert R. Freedman, PhD
Wayne State University
Detroit, MI
Ruth Freeman, MD
Albert Einstein College of Medicine
Bronx, NY
J. Chris Gallagher, MD
Creighton University
Omaha, NE
Andrea R. Genazzani, MD, PhD
University of Pisa
Pisa, Italy
Steven R. Goldstein, MD
NYU School of Medicine
New York, NY
George I. Gorodeski, MD, PhD
Case Western Reserve University
Cleveland, OH
Gail A. Greendale, MD
UCLA School of Medicine
Los Angeles, CA
Francine Grodstein, ScD
Harvard Medical School
Boston, MA
Charles B. Hammond, MD
Duke University Medical School
Durham, NC
Julia R. Heiman, PhD
Indiana University
Bloomington, IN
Victor W. Henderson, MD, MS
Stanford University School of Medicine
Stanford, CA
Risa Kagan, MD
University of California, San Francisco
San Francisco, CA
Bruce Kessel, MD
University of Hawaii at Manoa
Honolulu, HI
Sheryl A. Kinsberg, PhD
Case Western Reserve University
Cleveland, OH
Donna Kritz-Silverstein, PhD
University of California, San Diego
La Jolla, CA
Fredi Kronenberg, PhD
Columbia University
New York, NY
Karen Lifford, MD
Harvard Medical School
Boston, MA
Rogerio A. Lobo, MD
Columbia University
New York, NY
Charles Loprinzi, MD
Mayo Clinic
Rochester, MN
Tieraona Low Dog, MD
University of Arizona
Tucson, AZ
Pamela M. Maki, PhD
University of Illinois at Chicago
Chicago, IL
JoAnn E. Manson, MD, DrPH
Harvard Medical School
Boston, MA
| Karen A. Matthews, PhD
University of Pittsburgh
Pittsburgh, PA
Betsy L. McClung, RN, MN
Oregon Osteoporosis Center
Portland, OR
Michael R. McClung, MD
Providence Portland Medical Center
Portland, OR
Alfred O. Mueck, MD, PhD, PharmD
University Women’s Hospital of Tuebingen
Tuebingen, Germany
Alfonso Murillo-Uribe, MD
Hospita Angeles Lomas
Mexico City, Mexico
Lila E. Nachtigall, MD
NYU School of Medicine
New York, NY
Frederick Naftolin, MD, DPhil
Yale University School of Medicine
New Haven, CT
Carla Makhlouf Obermeyer, PhD, DSc
Harvard School of Public Health
Boston, MA
Diane T. Pace, PhD, FNP-BC, FAANP
University of Tennessee
College of Nursing
Memphis, TN
Amos Pines, MD
Tel Aviv University
Tel Aviv, Israel
JoAnn V. Pinkerton, MD
University of Virginia Health System
Charlottesville, VA
James K. Pru
Harvard Medical School
Boston, MA
Nancy King Reame, MSN, PhD
University of Michigan
Ann Arbor, MI
Quentin R. Regestein, MD
Harvard Medical School
Boston, MA
Marcie K. Richardson, MD
Harvard Medical School
Boston, MA
Walter A. Rocca, MD, MPH
Mayo Clinic
Rochester, MN
Raymond C. Rosen, PhD
Robert Wood Johnson Medical School
Piscataway, NJ
Miriam B. Rosenthal, MD
Case Western Reserve University
Cleveland, OH
Marilyn Rothert, PhD, RN
Michigan State University
School of Nursing
East Lansing, MI
Gören N. Samsioe, MD, PhD
Lund University
Lund , Sweden
Nanette F. Santoro, MD
Albert Einstein College of Medicine
Bronx, NY
Philip M. Sarrel, MD
Yale University School of Medicine
New Haven, CT
Raja A. Sayegh, MD
Boston University School of Medicine
Boston, MA
Peter F. Schnatz, DO
The Reading Hospital and Medical Center
Reading, PA
Peter E. Schwartz, MD
Yale University School of Medicine
New Haven, CT
Jan L. Shifren, MD
Harvard Medical School
Boston, MA
Lee P. Shulman, MD
Northwestern University
Chicago, IL
Lynette Leidy Sievert, PhD
University of Massachusetts, Amherst
Amherst, MA
James A. Simon, MD
George Washington University
Washington, DC
Regine L. Sitruk-Ware, MD
Rockefeller University
New York, NY
Claudio N. Soares, MD, PhD, FRCPC
McMaster University
Toronto, ON, Canada
Leon Speroff, MD
Oregon Health and Science University
Portland, OR
Meir J. Stampfer, MD, DrPH
Harvard Medical School
Harvard School of Public Health
Boston, MA
Frank Z. Stanczyk, PhD
University of Southern California
Los Angeles, CA
Jennifer Stark, ScD
Harvard School of Public Health
Boston, MA
Cynthia A. Stuenkel, MD
University of California, San Diego
La Jolla, CA
Hugh S. Taylor, MD
Yale University School of Medicine
New Haven, CT
Rebecca S. Thurston, PhD
University of Pittsburgh
Pittsburgh, PA
Mary Townsend, ScD
Harvard School of Public Health
Boston, MA
Mark G. Vangel, PhD
Harvard Medical School
Boston, MA
Michelle P. Warren, MD
Columbia University
New York, NY
Robert A. Wild, MD, PhD, MPH
University of Oklahoma
Oklahoma City, OK
Nancy Fugate Woods, PhD, RN
University of Washington
School of Nursing
Seattle, WA |
2009-2010 NAMS Board Of Trustees |
Cynthia A. Stuenkel, MD
President
Steven R. Goldstein, MD
President-Elect
Risa Kagan, MD
Teasurer
JoAnn E. Manson, MD, DrPH
Secretary
Thomas B. Clarkson, DVM
Elizabeth Contestabile, RN, BScN
Robert R. Freedman, PhD
Pauline M. Maki, PhD
Diane T. Pace, PhD, FNP
JoAnn V. Pinkerton, MD
Jan L. Shifren, MD
Leon Speroff, MD
Michelle P. Warren, MD
Ex-Officio
Isaac Schiff, MD
Wulf H. Utian, MD, PhD, DSc(Med) |
|
